Protocol for the examination of specimens from patients with primary pituitary tumors

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 5, 2011, Pages 640-646

  Nosé, Vania ^a   Ezzat, Shereen ^b   Horvath, Eva ^c   Knvacs, Kaiman ^c   Laws, Edward R ^d   Lloyd, Ricardo ^e   Lopes, M Beatriz S ^f   Asa, Sylvia L ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADENOMA; ARTICLE; CARCINOMA; CHECKLIST; CLINICAL PROTOCOL; CRANIOPHARYNGIOMA; HUMAN; HYPERPLASIA; HYPOPHYSIS TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; STANDARD;

ADENOMA; BIOLOGICAL MARKERS; CARCINOMA; CHECKLIST; CLINICAL PROTOCOLS; CRANIOPHARYNGIOMA; HUMANS; HYPERPLASIA; PATHOLOGY, SURGICAL; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79956322535     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours; vol 8.
2. Asa SL. Tumors of the Pituitary Gland. Washington, DC: Armed Forces Institute of Pathology; 1998. Rosai J, ed. Atlas of Tumor Pathology, 3rd series, fascicle 22.
3. Coire Cl, Horvath E, Kovacs K, Smyth HS, Ezzat S. Cushing's syndrome from an ectopic pituitary adenoma with peliosis: a histological, immunohistochemical and ultrastructural study and review of the literature. Endocr Pathol. 1997;8(1): 65-74. (Pubitemid 127499993)
4. Kikuchi K, Kowada M, Sasaki J, Sageshima M. Large pituitary adenoma of the sphenoid sinus and the nasopharynx: report of a case with ultrastructural evaluations. Surg Neurol. 1994;42(4):330-334. (Pubitemid 24350952)
5. Slonim SM, Haykal HA, Cushing GW, Freidberg SR, Lee AK. MRI appearances of an ectopic pituitary adenoma: case report and review of the literature. Neuroradiology. 1993;35(7):546-548. (Pubitemid 23252294)
6. Lloyd RV, Chandler WF, Kovacs K, Ryan N. Ectopic pituitary adenomas with normal anterior pituitary glands. Am J Surg Pathol. 1986,10(8):546-552. (Pubitemid 16069498)
7. Lewin R, Ruffolo E, Saraceno C. Craniopharyngioma arising in the pharyngeal hypophysis. Southern Med J. 1984;77(12):519-523.
8. Koral K, Weprin B, Rollins NK. Sphenoid sinus craniopharyngioma simulating mucocele. Acta Radiol. 2006;47(5):494-496. (Pubitemid 43862302)
9. van der Mey AG, van Seters AP, van Krieken JH, Vielvoye J, Van Dulken H, Hulshof JH. Large pituitary adenomas with extension into the nasopharynx: report of three cases with a review of the literature. Ann Otol Rhinol Laryngol. 1989; 98(8, pt 1):618-624. (Pubitemid 19219812)
10. Wong K, Raisanen J, Taylor SL, McDermott MW, Wilson CB, Gutin PH. Pituitary adenoma as an unsuspected clival tumor. Am J Surg Pathol. 1995,0 9(8): 900-903.
11. Hardy J. Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds. Diagnosis and Treatment of Pituitary Tumors. Amsterdam, The Netherlands: Exerpta Medica; 19730 79-198. International Congress Series; No 303.
12. Stefaneanu L, Kovacs K. Light microscopic special stains and immunohistochemistry in the diagnosis of pituitary adenomas. In: Lloyd RV, ed. Surgical Pathology of the Pituitary Gland. Philadelphia, PA: WB Saunders Company; 1993:34-51.
13. Thorner MO, Perryman RL, Cronin MJ, et al. Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 1982;70(5):965-977. (Pubitemid 13254920)
14. Bilbao JM, Horvath E, Hudson AR, Kovacs K. Pituitary adenoma producing amyloid-like substance. Arch Pathol Lab Med. 1975;99(8):411-415.
15. Landolt AM, Kleihues P, Heitz PhU. Amyloid deposits in pituitary adenomas: differentiation of two types. Arch Pathol Lab Med. 1987;111(5): 453-458. (Pubitemid 17073566)
16. Bilbao JM, Kovacs K, Horvath E, Higgins HP, Horsey WJ. Pituitary melanocorticotrophinoma with amyloid deposition. J Can Sei Neurol. 1975;2(3): 199-202.
17. Mori H, Mori S, Saitoh Y, Moriwaki K, lida S, Matsumoto K. Growth hormone-producing pituitary adenoma with crystal-like amyloid immunohistochemically positive for growth hormone. Cancer. 1985;55(1):96-102. (Pubitemid 15198205)
18. Voigt C, Saeger W, Gerigk Ch, Lüdecke DK. Amyloid in pituitary adenomas. Pathol Res Pract 1988;183(5):555-557.
19. Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg. 1986;65(6):733-744. (Pubitemid 17187407)
20. Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM. The occurrence of dural invasion in pituitary adenomas. J Neurosurg. 1986;64(3):402-407. (Pubitemid 16035061)
21. Sautner D, Saeger W. Invasiveness of pituitary adenomas. Pathol Res Pract 1991;187(5):632-636.
22. Horvath E, Kovacs K, Smyth HS, et al. A novel type of pituitary adenoma: morphological feature and clinical correlations. J Clin Endocrinol Metab. 1988; 66(6):1111-1118.
23. Anniko M, Tribukait B, Wersäll J. DNA ploidy and cell phase in human pituitary tumors. Cancer. 1984;53(8):1708-1713. (Pubitemid 14127510)
24. Fitzgibbons PL, Appley AJ, Turner RR, et al. Flow cytometric analysis of pituitary tumors: correlation of nuclear antigen p105 and DNA content with clinical behavior. Cancer. 1988;62(8):1556-1560.
25. Landott AM, Shibata T, Kleihues P. Growth rate of human pituitary adenomas. J Neurosurg. 1987;67(6):803-806. (Pubitemid 18005523)
26. Knosp E, Kitz K, Perneczky A. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery. 1989;25(6):927930.
27. Thapar K, Kovacs K, Scheithauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery. 1996;38(1):99-107. (Pubitemid 26002389)
28. Hsu DW, Hakim F, Biller BMK, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg. 1993;78(5):753-761. (Pubitemid 23121917)
29. Candour-Edwards R, Kapadia SB, Janečka IP, Martinez AJ, Barnes L. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol. 1995;8(2): 160-164.
30. Takino H, Herman V, Weiss M, Melmed S. Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab. 1995;80(5): 1733-1738.
31. Vidal S, Kovacs K, Horvath E, et al. Topoisomerase Ilalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior. Mod Pathol. 200205(11):1205-1212.
32. Al Shraim M, Asa SL. The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathol. 2006;111(1):1-7. (Pubitemid 43013820)
33. Kovacs K, Horvath E. Tumors of the Pituitary Gland. Washington, DC: Armed Forces Institute of Pathology; 1986. Atlas of Tumor Pathology, 2nd series, fascicle 21.
34. Kovacs K, Horvath E, Ryan N, Ezrin C. Null cell adenoma of the human pituitary. Virchows Arch [Pathol Anat]. 1980;387(2):165-174. (Pubitemid 10065185)
35. Barkan AL, Shenker Y, Grekin RJ, Vale WW, Lloyd RV, Beals TF. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. J Clin Endocrinol Metab. 1986;63(5):1 057-1064.
36. Khalil A, Kovacs K, Sima AAF, Burrow GN, Horvath E. Pituitary thyrotroph hyperplasia mimicking prolactin-secreting adenoma. J Endocrinol Invest 1984; 7(4):399-404. (Pubitemid 14014318)
37. Chan AW, MacFarlane IA, Foy PM, Miles JB. Pituitary enlargement and hyperprolactinaemia due to primary hypothyroidism: errors and delays in diagnosis. Br J Neurosurg. 1990;4(2): 107-112. (Pubitemid 20278838)
38. Saeger W, Lüdecke DK. Pituitary hyperplasia: definition, light and electron microscopical structures and significance in surgical specimens. Virchows Arch [A]. 1983;399(3):2 77-287.
39. Thorner MO, Frohman LA, Leong DA, et al. Extrahypothalamic growth hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab. 1984;59(5): 846-849. (Pubitemid 14020682)
40. Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SL, eds. Functional Endocrine Pathology. Boston, MA: Blackwell Scientific Publications; 1991,-245-281.
41. Moran A, Asa SL, Kovacs K, et al. Gigantism due to pituitary mammosomatotroph hyperplasia. N Engl J Med. 1990;323(5):322-327. (Pubitemid 20237098)
42. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch. 2001;438(6):595-602. (Pubitemid 32662379)
43. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery. 1996;38(4):765-771. (Pubitemid 26087884)
44. Jin L, Qian X, Kulig E, et al. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol. 1997;151(2):509-519. (Pubitemid 27330070)
45. Korbonits M, Chahal HS, Kaltsas G, et al. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab. 2002;87(6):2635-2643. (Pubitemid 34655325)
46. Nosé-Alberti V, Mesquita MI, Martin LC, Kayath MJ. Adrenocorticotropinproducing pituitary carcinoma with expression of c-erbB-2 and high PCNA index: a comparative study with pituitary adenomas and normal pituitary tissues. Endocr Pathol. 1998;9(1):53-62. (Pubitemid 28304406)
47. Baskin DS, Wilson CB. Surgical management of craniopharyngiomas: a review of 74 cases. J Neurosurg. 1986;65(1):22-27. (Pubitemid 16059898)
48. Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab. 1999;84(10:3972-3982.
49. Petito CK, DeGirolami U, Earle KM. Craniopharyngiomas: a clinical and pathological review. Cancer. 1976;37(4): 1944-1952.
50. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007. IARC WHO Classification of Tumours; vol 1.
51. Crooke AC. A change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenoma. J Pathol Bacteriol. 1935;41:339-349.
52. Kovacs K, Horvath E, Ryan N. Immunocytology of the human pituitary. In: DeLellis RA, ed. Diagnostic Immunohistochemistry. New York, NY: Masson Publishing USA; 1981, 17-35.
53. Neumann PE, Horoupian DS, Goldman JE, Hess MA. Cytoplasmic filaments of Crooke's hyaline change belong to the cytokeratin class: an immunocytochemical and ultrastructural study. Am J Pathol. 1984;116(2):214-222. (Pubitemid 14053912)
54. Eschbacher JM, Coons SW. Cytokeratin CK20 is a sensitive marker for Crooke's cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs. Endocr Pathol. 2006, 17(4):365-376.
55. Newell-Price J , Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev. 1998,19(5):647-672.